COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,649 Articles (22,913 medRxiv, 8,736 bioRxiv)

Most recent first Previous |  Page 886: Articles 8851-8860  | Next

What factors converged to create a COVID-19 hot-spot? Lessons from the South Asian community in Ontario.
Anand, S. S., Arnold, C., Bangdiwala, S. I., Bolotin, S., Bowdish, D., Chanchlani, R., de Souza, R., Desai, D., Kandasamy, S., Khan, F., Khan, Z., Langlois, M.-A., Limbachia, J., Lear, S., Loeb, M., Loh, L. C., Manoharan, B., Nakka, K., Pelchat, M., Punthakee, Z., Schulze, K. M., Williams, N. C., Wahi, G.
10.1101/2022.04.01.22273252 — Posted: 2022-04-01
Internet and mental health during the COVID-19 pandemic: Evidence from the UK
Quintana-Domeque, C., Zeng, J., Zhang, X.
10.1101/2022.04.01.22273299 — Posted: 2022-04-01
Consistent Pattern of Epidemic Slowing Across Many Geographies Led to Longer, Flatter Initial Waves of the COVID-19 Pandemic
Ben-Nun, M., Riley, P., Turtle, J. A., Riley, S.
10.1101/2022.03.31.22273267 — Posted: 2022-04-01
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation: test negative case-control study
Stowe, J., Andrews, N., Kirsebom, F., Ramsay, M., Lopez Bernal, J.
10.1101/2022.04.01.22273281 — Posted: 2022-04-01
Modeling and Global Sensitivity Analysis of Strategies to Mitigate Covid-19 Transmission on a Structured College Campus
Zhao, L., Santiago, F., Rutter, E. M., Khatri, S., Sindi, S.
10.1101/2022.04.01.22273316 — Posted: 2022-04-01
Interpretation of non-responders to SARS-CoV-2 vaccines using WHO International Standard
Zeng, Q., Yang, X., Gao, Q., Lin, B.-y., Li, Y.-z., Huang, G., Xu, Y.
10.1101/2022.03.31.22273272 — Posted: 2022-04-01
The impact of COVID-19 pandemic on influenza surveillance: a systematic review and meta-analysis
Sabeena, S., Ravishankar, N., Robin, S.
10.1101/2022.03.31.22273236 — Posted: 2022-04-01
Engagement of health workers and peer educators from the National Adolescent Health Programme-Rashtriya Kishor Swasthya Karyakram during the COVID-19 pandemic: findings from a situational analysis
Arora, M., Dringus, S., Bahl, D., Rizvi, Z., Maity, H., Lama, S., Mason-Jones, A. J., Kumar, D., Koul, P., Bassi, S.
10.1101/2022.03.28.22273059 — Posted: 2022-04-01
Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial
Ader, F., Bouscambert Duchamp, M., Hites, M., Peiffer Smadja, N., Poissy, J., Belhadi, D., Diallo, A., Delmas, C., Saillard, J., Dechanet, A., Fougerou, C., Le, M. P., Peytavin, G., Mercier, N., Velou, P., Tubiana, S., Lescure, X., Faure, E., Nseir, S., Richard, J. C., Wallet, F., Goehringer, F., Lefevre, B., Kimmoun, A., Raffi, F., Gaborit, B., Reignier, J., Lanoix, J. P., Andrejak, C., Zerbib, Y., Bani Sadr, F., Mourvilliers, B., Danion, F., Ruch, Y., Clere Jehl, R., Le Moing, V., Klouche, K., Lacombe, K., Martin Blondel, G., Vardon Bounes, F., Cabie, A., Turmel, J. M., Piroth, L., Blot, M., Botelho Nevers, E., Gagneux Brunon, A., Thiery, G., Benezit, F., Gaci, R., Mootien, J., Gallien, S., Garot, D., Bouiller, K., Epelboin, L., Jaureguiberry, S., Gaymard, A., Verschelden, G., Braz, S., Ferreira Ribeiro, J. M., Joannidis, M., Staub, T., Altdorfer, A., Greil, R., Egle, A., Guedj, J., Noret, M., Roncon Albuquerque, R., Paiva, J. A., Lina, B., Costagliola, D., Yazdanpanah, Y., Burdet, C., Mentre, F., DisCoVeRy Study Group
10.1101/2022.03.30.22273206 — Posted: 2022-03-31
Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19
Recktenwald, S. M., Simionato, G., G.M. Lopes, M., Gamboni, F., Dzieciatkowska, M., Meybohm, P., Zacharowski, K., von Knethen, A., Wagner, C., Kaestner, L., D'Alessandro, A., Quint, S.
10.1101/2022.03.31.22273226 — Posted: 2022-03-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).